Explore
Validate
Learn
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA015801 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA015801, RRID:AB_1858830
- Product name
- Anti-NSD2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human NSD2, Gene description: nuclear receptor binding SET domain protein 2, Alternative Gene Names: KMT3G, MMSET, WHSC1, Validated applications: IHC, ICC, Uniprot ID: O96028, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.3 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation
HIRA Is Required for Heart Development and Directly Regulates Tnni2 and Tnnt3
Histone Lysine Methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in Human Carcinogenesis through Regulation of the Wnt Pathway
Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
Dong P, Xiong Y, Yue J, Hanley S, Watari H
Oncotarget 2018;9(33):23253-23263
Oncotarget 2018;9(33):23253-23263
HIRA Is Required for Heart Development and Directly Regulates Tnni2 and Tnnt3
Fraidenraich D, Dilg D, Saleh R, Phelps S, Rose Y, Dupays L, Murphy C, Mohun T, Anderson R, Scambler P, Chapgier A
PLOS ONE 2016;11(8):e0161096
PLOS ONE 2016;11(8):e0161096
Histone Lysine Methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in Human Carcinogenesis through Regulation of the Wnt Pathway
Toyokawa G, Cho H, Masuda K, Yamane Y, Yoshimatsu M, Hayami S, Takawa M, Iwai Y, Daigo Y, Tsuchiya E, Tsunoda T, Field H, Kelly J, Neal D, Maehara Y, Ponder B, Nakamura Y, Hamamoto R
Neoplasia 2011;13(10):887-IN11
Neoplasia 2011;13(10):887-IN11
Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
Toyokawa G, Cho HS, Masuda K, Yamane Y, Yoshimatsu M, Hayami S, Takawa M, Iwai Y, Daigo Y, Tsuchiya E, Tsunoda T, Field HI, Kelly JD, Neal DE, Maehara Y, Ponder BA, Nakamura Y, Hamamoto R
Neoplasia (New York, N.Y.) 2011 Oct;13(10):887-98
Neoplasia (New York, N.Y.) 2011 Oct;13(10):887-98
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human testis and liver tissues using Anti-NSD2 antibody. Corresponding NSD2 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
